Spanish Pharma Stock News

Gestamp Automoción, S.A. has announced its third quarter 2025 results, reporting net income of €29.9 million, up from €20.9 million a year earlier, despite sales and revenue declines for both the quarter and the first nine months of the year. This outcome highlights the company's ability to improve profitability even as overall revenue and sales figures moved lower compared to the prior year period. We'll explore how Gestamp Automoción's higher quarterly net income amid ongoing revenue...

Técnicas Reunidas, S.A. reported earnings for the nine months ended September 30, 2025, with sales rising to €4.60 billion and net income reaching €106.9 million, both up from the same period last year. This earnings report reflects improved business performance and financial health, as the company recorded higher sales, revenue, and net income year-over-year. We'll explore how Técnicas Reunidas' substantial year-on-year sales and income growth may influence its investment narrative and...

Cementos Molins reported earnings results on October 30, 2025, announcing that sales for the nine months ended September 30 reached €751.4 million, with net income at €140.6 million, both down from the previous year. This decline in sales and net income stands out as a signal of changing business conditions impacting the company's financial performance this year. With both top- and bottom-line results decreasing, we’ll examine how these latest earnings figures shape Cementos Molins’...

Cellnex Telecom reported its third quarter and nine-month 2025 earnings, with sales rising to €995 million and €2.94 billion respectively, but shifting to a net loss of €148 million for the quarter and €263 million for the period. While revenues showed modest year-over-year growth, the transition from positive net income to losses may raise questions regarding cost management and profitability amid expansion efforts. We will explore how Cellnex's move from profit to net loss could impact its...

Acerinox, S.A. announced its financial results for the third quarter and nine months ended September 30, 2025, reporting sales of €1,415 million for Q3 and net income of €25 million, compared to €1,307 million and €48 million, respectively, a year earlier. While sales increased year-on-year for both the quarter and the nine-month period, net income declined sharply, underscoring ongoing margin pressures in a challenging market. We'll examine how the pronounced drop in net income relative to...

On November 4, 2025, Grifols, S.A. held its Q3 2025 earnings call, releasing new details about its recent financial performance and company outlook. This earnings report provides key insights into the company's operations and may influence investor sentiment given its importance as an indicator of business momentum and financial health. Now, we'll explore how the recent Q3 earnings disclosure could impact Grifols' investment narrative and future financial projections. The end of cancer?...

It's been a good week for Almirall, S.A. ( BME:ALM ) shareholders, because the company has just released its latest...

Logista Integral, S.A. has released its full-year earnings results for the period ended September 30, 2025, reporting sales of €13.54 billion compared to €12.99 billion a year earlier, while net income declined to €281 million from €308 million. Although sales increased, the fall in net income highlights shifting profit dynamics even as top-line growth continues, signaling a complex operating environment for the company. We'll explore how Logista Integral's higher sales but lower net income...

Unicaja Banco (BME:UNI) just shared its latest earnings, revealing higher net income for both the third quarter and first nine months of 2025 compared to last year. This steady profit growth stands out to investors. See our latest analysis for Unicaja Banco. After a surge in net income, Unicaja Banco’s share price has raced ahead with a year-to-date price return of 103.34 percent. Momentum has clearly been building, supported by a stellar 1-year total shareholder return of 143.32 percent...

On October 29, 2025, Endesa, S.A. confirmed its full-year 2025 earnings guidance, stating it expects net income to reach the upper end of its previously forecast range. This update signals strengthened management confidence in Endesa's financial outlook and operational progress against its strategic targets for the year. Let's examine how Endesa's raised earnings guidance shapes expectations for its long-term profitability and growth outlook. Trump's oil boom is here - pipelines are primed...

Meliá Hotels International recently reported its financial results for the third quarter and nine months ended September 30, 2025, posting increases in sales, revenue, and net income compared to the previous year. An interesting insight from the results is that the company achieved higher net income over the nine-month period despite ongoing pressures related to operating costs and regional exposure. We'll explore how Meliá's ability to deliver steady earnings growth impacts its overall...

Prosegur Compañía de Seguridad, S.A. reported earnings results for the nine months ended September 30, 2025, with sales of €3.67 billion and net income of €82 million, both higher than the previous year. This performance highlights a substantial improvement in profitability, with net income widening more than €29 million compared to the same period last year. We'll explore how Prosegur's significant net income increase bolsters its investment narrative and potential for sustained financial...

Faes Farma, S.A. recently reported its earnings for the nine months ended September 30, 2025, highlighting sales of €440.95 million and revenue of €454 million, both higher than the prior year, while net income decreased to €73.56 million. Despite higher sales and revenue, the company's lower net income reveals a shift in its profit dynamics during this reporting period. We'll explore how the rise in sales alongside a lower net income influences Faes Farma's investment narrative going...

On October 30, 2025, Puig Brands reaffirmed its earnings guidance for the full year, maintaining like-for-like revenue growth expectations in the 6% to 8% range. This steady outlook, confirmed just after its Q3 2025 earnings call, reflects management’s confidence in the underlying momentum of Puig Brands’ business performance. We’ll explore how management’s reaffirmation of growth guidance shapes Puig Brands’ investment narrative and outlook moving into year-end. Explore 27 top quantum...

Repsol reported its third-quarter 2025 results, revealing sales of €13.09 billion and net income of €574 million, compared to €13.60 billion and €166 million a year earlier. This sharp increase in quarterly profitability came despite slightly lower sales, highlighting a change in Repsol's earnings profile for the period. We will explore how the strong rise in quarterly net income factors into Repsol's overall investment outlook and future earnings trajectory. The end of cancer? These 29...

On October 31, 2025, Mapfre, S.A. reported its earnings for the nine months ended September 30, 2025, posting net income of €829 million, up from €653.5 million a year earlier. This marks a considerable improvement in profitability, reflecting effective cost controls and potentially stronger underwriting across key insurance segments. Next, we’ll assess how Mapfre’s increased net income provides new context for its investment outlook and long-term growth drivers. Outshine the giants: these...

Almirall (BME:ALM) shares have moved slightly higher in the past day, drawing interest from investors curious about recent trading activity and what may be driving sentiment for the Spanish pharmaceutical company. Recent performance trends suggest a mix of caution and optimism. See our latest analysis for Almirall. Almirall’s latest 1.9% share price bump comes after a strong few months, building momentum on a year-to-date price return of nearly 41%. For long-term holders, the total...

Ebro Foods (BME:EBRO) has attracted attention following a recent shift in its stock performance over the past month. This development is sparking interest among investors who are weighing potential upside against recent returns. The company's steady strategy remains a key discussion point. See our latest analysis for Ebro Foods. While Ebro Foods’ share price slipped slightly in the past day, it still posts an 11.4% gain year-to-date and a total shareholder return of 13.7% over the last year...

Amadeus IT Group (BME:AMS) delivered third-quarter earnings that topped expectations, with both revenue and profit coming in ahead of consensus. The company’s outperformance was supported by stronger travel bookings and consistent growth across key markets. See our latest analysis for Amadeus IT Group. After a solid earnings beat and upbeat guidance, Amadeus IT Group's share price has shown only modest movement this year. The 1-year total shareholder return stands just below flat, reflecting...

Amadeus IT Group reported its third quarter and nine-month 2025 financial results, showing year-over-year growth in sales to €1.63 billion and net income to €360.8 million for the quarter ended September 30, 2025. This ongoing growth in both sales and earnings reflects operational momentum and continued market demand for Amadeus's services across its business lines. With third quarter net income up from a year ago, we'll examine how this earnings update further impacts Amadeus IT Group's...

It's been a mediocre week for Laboratorios Farmaceuticos Rovi, S.A. ( BME:ROVI ) shareholders, with the stock dropping...

With its stock down 3.3% over the past month, it is easy to disregard Cementos Molins (BDM:CMO). However, stock prices...

The market for Repsol, S.A.'s ( BME:REP ) shares didn't move much after it posted weak earnings recently. We did some...

Gestamp Automoción (BME:GEST) reported a net profit margin of 1.4%, slightly below last year’s 1.5%, following a year of negative earnings growth despite averaging a robust 25.2% annual improvement in profitability over the past five years. The stock currently trades at €2.87, which is well below its estimated fair value of €5.84. A price-to-earnings ratio of 9.8x sets it apart as attractively valued compared to industry benchmarks. Looking ahead, investors will be watching the company’s...